Evanson Asset Management’s Corbus Pharmaceuticals CRBP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-667
| Closed | -$109K | – | 223 |
|
|
2019
Q4 | $109K | Hold |
667
| – | – | 0.02% | 231 |
|
|
2019
Q3 | $97K | Sell |
667
-26
| -4% | -$3.78K | 0.02% | 230 |
|
|
2019
Q2 | $144K | Buy |
693
+16
| +2% | +$3.33K | 0.03% | 230 |
|
|
2019
Q1 | $141K | Hold |
677
| – | – | 0.03% | 231 |
|
|
2018
Q4 | $119K | Hold |
677
| – | – | 0.03% | 219 |
|
|
2018
Q3 | $153K | Hold |
677
| – | – | 0.03% | 227 |
|
|
2018
Q2 | $103K | Hold |
677
| – | – | 0.02% | 245 |
|
|
2018
Q1 | $124K | Hold |
677
| – | – | 0.03% | 245 |
|
|
2017
Q4 | $144K | Hold |
677
| – | – | 0.03% | 238 |
|
|
2017
Q3 | $145K | Sell |
677
-12
| -2% | -$2.57K | 0.03% | 223 |
|
|
2017
Q2 | $130K | Buy |
689
+10
| +1% | +$1.89K | 0.03% | 215 |
|
|
2017
Q1 | $168K | Buy |
679
+12
| +2% | +$2.97K | 0.04% | 213 |
|
|
2016
Q4 | $169K | Hold |
667
| – | – | 0.05% | 206 |
|
|
2016
Q3 | $136K | Hold |
667
| – | – | 0.04% | 193 |
|
|
2016
Q2 | $60K | Buy |
667
+334
| +100% | +$30K | 0.02% | 199 |
|
|
2016
Q1 | $18K | Hold |
333
| – | – | 0.01% | 198 |
|
|
2015
Q4 | $17K | Hold |
333
| – | – | 0.01% | 199 |
|
|
2015
Q3 | $16K | Buy |
+333
| New | +$16K | 0.01% | 203 |
|